Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? (original) (raw)

• Embley, T. M. & Martin, W. Eukaryotic evolution, changes and challenges. Nature 440, 623–630 (2006).
  Article CAS PubMed Google Scholar
• Martin, W., Hoffmeister, M., Rotte, C. & Henze, K. An overview of endosymbiotic models for the origins of eukaryotes, their ATP-producing organelles (mitochondria and hydrogenosomes), and their heterotrophic lifestyle. Biol. Chem. 382, 1521–1539 (2001).
  Article CAS PubMed Google Scholar
• Timmis, J. N., Ayliffe, M. A., Huang, C. Y. & Martin, W. Endosymbiotic gene transfer: organelle genomes forge eukaryotic chromosomes. Nature Rev. Genet. 5, 123–135 (2004).
  Article CAS PubMed Google Scholar
• Adams, K. L. & Palmer, J. D. Evolution of mitochondrial gene content: gene loss and transfer to the nucleus. Mol. Phylogenet. Evol. 29, 380–395 (2003).
  Article CAS PubMed Google Scholar
• Murphy, M. P. et al. Unraveling the biological roles of reactive oxygen species. Cell. Metab. 13, 361–366 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chance, B., Sies, H. & Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527–605 (1979).
  Article CAS PubMed Google Scholar
• Quinlan, C. L. et al. The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex I. J. Biol. Chem. 289, 8312–8325 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Gardner, P. R. Superoxide-driven aconitase FE-S center cycling. Biosci. Rep. 17, 33–42 (1997).
  Article CAS PubMed Google Scholar
• Guzy, R. D. & Schumacker, P. T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 91, 807–819 (2006).
  Article CAS PubMed Google Scholar
• Fabian, M. & Palmer, G. Hydrogen peroxide is not released following reaction of cyanide with several catalytically important derivatives of cytochrome c oxidase. FEBS Lett. 422, 1–4 (1998).
  Article CAS PubMed Google Scholar
• Han, D., Antunes, F., Canali, R., Rettori, D. & Cadenas, E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J. Biol. Chem. 278, 5557–5563 (2003).
  Article CAS PubMed Google Scholar
• Bienert, G. P. et al. Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282, 1183–1192 (2007).
  Article CAS PubMed Google Scholar
• Waypa, G. B. et al. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ. Res. 106, 526–535 (2010). This study demonstrates how hypoxia-induced changes in mitochondrial ROS generation affect redox status in subcellular compartments differently.
  Article CAS PubMed Google Scholar
• Sabharwal, S. S., Waypa, G. B., Marks, J. D. & Schumacker, P. T. Peroxiredoxin-5 targeted to the mitochondrial intermembrane space attenuates hypoxia-induced reactive oxygen species signalling. Biochem. J. 456, 337–346 (2013).
  Article CAS PubMed Google Scholar
• Mills, G. C. Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J. Biol. Chem. 229, 189–197 (1957).
  CAS PubMed Google Scholar
• Morgan, B. et al. Multiple glutathione disulfide removal pathways mediate cytosolic redox homeostasis. Nature Chem. Biol. 9, 119–125 (2013).
  Article CAS Google Scholar
• Chae, H. Z. & Rhee, S. G. A thiol-specific antioxidant and sequence homology to various proteins of unknown function. Biofactors 4, 177–180 (1994).
  CAS PubMed Google Scholar
• Kim, K., Kim, I. H., Lee, K. Y., Rhee, S. G. & Stadtman, E. R. The isolation and purification of a specific “protector” protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system. J. Biol. Chem. 263, 4704–4711 (1988).
  CAS PubMed Google Scholar
• Rhee, S. G., Chae, H. Z. & Kim, K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543–1552 (2005).
  Article CAS PubMed Google Scholar
• Fan, J. et al. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510, 298–302 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Lewis, C. A. et al. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell 55, 253–263 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Holmgren, A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264, 13963–13966 (1989).
  CAS PubMed Google Scholar
• Rhee, S. G., Jeong, W., Chang, T. S. & Woo, H. A. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int. Suppl. S3–S8 (2007).
• Arner, E. S. & Holmgren, A. The thioredoxin system in cancer. Semin. Cancer Biol. 16, 420–426 (2006). This excellent review summarizes the role of thioredoxin and its contributions to the cellular phenotype of cancer cells.
  Article CAS PubMed Google Scholar
• Padmanabhan, B. et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689–700 (2006).
  Article CAS PubMed Google Scholar
• Singh, A., Bodas, M., Wakabayashi, N., Bunz, F. & Biswal, S. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid. Redox. Signal. 13, 1627–1637 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Shibata, T. et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA 105, 13568–13573 (2008).
  Article PubMed PubMed Central Google Scholar
• Sullivan, L. B. et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236–248 (2013). This study examines the mechanisms by which FH deficiency drives tumour cell behaviour in a redox-dependent manner.
  Article CAS PubMed PubMed Central Google Scholar
• Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009). This excellent review summarizes the role of the Warburg effect on cell proliferation.
  Article CAS PubMed PubMed Central Google Scholar
• Le, A. et al. Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter. Proc. Natl Acad. Sci. USA 111, 12486–12491 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Waypa, G. B. et al. Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. Am. J. Respir. Crit. Care Med. 187, 424–432 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Farrow, K. N. et al. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells. Antioxid. Redox. Signal. 17, 460–470 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Chandel, N. S. et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95, 11715–11720 (1998). This study was the first to demonstrate that mitochondria-derived ROS can regulate transcription through their control of HIF1α stability.
  Article CAS PubMed PubMed Central Google Scholar
• Waypa, G. B. et al. Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ. Res. 99, 970–978 (2006).
  Article CAS PubMed Google Scholar
• Chi, A. Y., Waypa, G. B., Mungai, P. T. & Schumacker, P. T. Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells. Antioxid. Redox. Signal. 12, 603–610 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Guzy, R. D. et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell. Metab. 1, 401–408 (2005). This study demonstrated the importance of mitochondrial complex III in hypoxia-induced ROS generation that controls HIF1α stability.
  Article CAS PubMed Google Scholar
• Mansfield, K. D. et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell. Metab. 1, 393–399 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Bell, E. L., Emerling, B. M. & Chandel, N. S. Mitochondrial regulation of oxygen sensing. Mitochondrion. 5, 322–332 (2005).
  Article CAS PubMed Google Scholar
• Weinberg, F. et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl Acad. Sci. USA 107, 8788–8793 (2010). This study examines the role of mitochondrial ROS signalling in the tumorigenic behaviour induced by KRAS activation.
  Article PubMed PubMed Central Google Scholar
• Sanjuan-Pla, A. et al. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1α. FEBS Lett. 579, 2669–2674 (2005).
  Article CAS PubMed Google Scholar
• Hamanaka, R. B. et al. Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci. Signal. 6, ra8 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Woo, D. K. et al. Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in APCMin/+ mice. Am. J. Pathol. 180, 24–31 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Brandon, M., Baldi, P. & Wallace, D. C. Mitochondrial mutations in cancer. Oncogene 25, 4647–4662 (2006). This is an excellent review of the evidence linking mtDNA mutations and cancer.
  Article CAS PubMed Google Scholar
• Ishikawa, K. et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320, 661–664 (2008). This study demonstrates that mtDNA mutations can amplify tumour progression by increasing cellular ROS generation.
  Article CAS PubMed Google Scholar
• Alexeyev, M., Shokolenko, I., Wilson, G. & Ledoux, S. The maintenance of mitochondrial DNA integrity—critical analysis and update. Cold Spring Harb. Perspect. Biol. 5, a012641 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Larsen, N. B., Rasmussen, M. & Rasmussen, L. J. Nuclear and mitochondrial DNA repair: similar pathways? Mitochondrion 5, 89–108 (2005).
  Article CAS PubMed Google Scholar
• He, Y. et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464, 610–614 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Clayton, D. A. & Vinograd, J. Circular dimer and catenate forms of mitochondrial DNA in human leukaemic leucocytes. Nature 216, 652–657 (1967).
  Article CAS PubMed Google Scholar
• Clayton, D. A. & Vinograd, J. Complex mitochondrial DNA in leukemic and normal human myeloid cells. Proc. Natl Acad. Sci. USA 62, 1077–1084 (1969).
  Article CAS PubMed PubMed Central Google Scholar
• Polyak, K. et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature Genet. 20, 291–293 (1998).
  Article CAS PubMed Google Scholar
• Kulawiec, M., Salk, J. J., Ericson, N. G., Wanagat, J. & Bielas, J. H. Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer. Environ. Mol. Mutagen 51, 427–439 (2010).
  CAS PubMed Google Scholar
• Chatterjee, A., Mambo, E. & Sidransky, D. Mitochondrial DNA mutations in human cancer. Oncogene 25, 4663–4674 (2006).
  Article CAS PubMed Google Scholar
• Coller, H. A. et al. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nature Genet. 28, 147–150 (2001).
  Article CAS PubMed Google Scholar
• Zhidkov, I., Livneh, E. A., Rubin, E. & Mishmar, D. MtDNA mutation pattern in tumors and human evolution are shaped by similar selective constraints. Genome Res. 19, 576–580 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Linnartz, B., Anglmayer, R. & Zanssen, S. Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res. 64, 1966–1971 (2004). This study tracked the association between the increase in mtDNA mutations over time and the progression from myelodysplastic syndrome to acute myeloid leukaemia in patients.
  Article CAS PubMed Google Scholar
• Kirches, E. et al. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int. J. Cancer 93, 534–538 (2001).
  Article CAS PubMed Google Scholar
• Petros, J. A. et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl Acad. Sci. USA 102, 719–724 (2005). This study used cellular cybrids to examine the role of mtDNA mutations on ROS generation and tumorigenicity in prostate cancer cells.
  Article CAS PubMed PubMed Central Google Scholar
• Trounce, I., Neill, S. & Wallace, D. C. Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc. Natl Acad. Sci. USA 91, 8334–8338 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Mattiazzi, M. et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum. Mol. Genet. 13, 869–879 (2004).
  Article CAS PubMed Google Scholar
• Shidara, Y. et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 65, 1655–1663 (2005).
  Article CAS PubMed Google Scholar
• Vazquez, F. et al. PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23, 287–301 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Namslauer, I. & Brzezinski, P. A mitochondrial DNA mutation linked to colon cancer results in proton leaks in cytochrome c oxidase. Proc. Natl Acad. Sci. USA 106, 3402–3407 (2009).
  Article PubMed PubMed Central Google Scholar
• Samper, E., Nicholls, D. G. & Melov, S. Mitochondrial oxidative stress causes chromosomal instability of mouse embryonic fibroblasts. Aging Cell 2, 277–285 (2003).
  Article CAS PubMed Google Scholar
• VanRemmen, H. et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genom. 16, 29–37 (2003).
  Article CAS Google Scholar
• Liu, L., Trimarchi, J. R., Smith, P. J. & Keefe, D. L. Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell 1, 40–46 (2002).
  Article CAS PubMed Google Scholar
• Martinez-Outschoorn, U. E. et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 9, 3256–3276 (2010).
  CAS PubMed PubMed Central Google Scholar
• Degan, P. et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 16, 735–741 (1995).
  Article CAS PubMed Google Scholar
• Ponte, F. et al. Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine. Orphanet. J. Rare. Dis. 7, 28 (2012).
  Article PubMed PubMed Central Google Scholar
• Radisky, D. C. et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123–127 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Gerasimenko, J. V. et al. Menadione-induced apoptosis: roles of cytosolic Ca2+ elevations and the mitochondrial permeability transition pore. J. Cell Sci. 115, 485–497 (2002).
  CAS PubMed Google Scholar
• Bernardi, P. Mitochondrial transport of cations: Channels, exchangers, and permeability transition. Physiol. Rev. 79, 1127–1155 (1999).
  Article CAS PubMed Google Scholar
• Giorgio, V. et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl Acad. Sci. USA 110, 5887–5892 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662 (2005).
  Article CAS PubMed Google Scholar
• Loor, G. et al. Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion. Biochim. Biophys. Acta 1813, 1382–1394 (2011).
  Article CAS PubMed Google Scholar
• Schriewer, J. M., Peek, C. B., Bass, J. & Schumacker, P. T. ROS-mediated, PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J. Am. Heart Assoc. 2, e000159 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Dewhirst, M. W., Cao, Y. & Moeller, B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nature Rev. Cancer 8, 425–437 (2008).
  Article CAS Google Scholar
• Trachootham, D. et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10, 241–252 (2006).
  Article CAS PubMed Google Scholar
• Lee, S. R. et al. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277, 20336–20342 (2002). This study demonstrated how H 2 O 2 generation can lead to the reversible inactivation of the lipid phosphatase PTEN, with important implications for cancer cell growth driven by excessive ROS signalling.
  Article CAS PubMed Google Scholar
• Kwon, J. et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl Acad. Sci. USA 101, 16419–16424 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, P. et al. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 12, 230–238 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634 (2010). This is an excellent review of the role of HIF1 in cancer.
  Article CAS PubMed Google Scholar
• Keith, B. & Simon, M. C. Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465–472 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Semenza, G. L. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin. Cancer Biol. 19, 12–16 (2009).
  Article CAS PubMed Google Scholar
• Huang, L. E., Gu, J., Schau, M. & Bunn, H. F. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 95, 7987–7992 (1998). This is a classic paper describing the regions of the HIF1α protein that confer sensitivity to hypoxia.
  Article CAS PubMed PubMed Central Google Scholar
• Epstein, A. C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001). This study demonstrates the importance of SDH mutations in the formation of hereditary paragangliomas, thereby linking mitochondria to tumorigenic behaviour.
  Article CAS PubMed Google Scholar
• Ivan, M. et al. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464–468 (2001).
  Article CAS PubMed Google Scholar
• Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).
  Article CAS PubMed Google Scholar
• Chandel, N. S. et al. Reactive oxygen species generated at mitochondrial Complex III stabilize HIF-1-α during hypoxia: A mechanism of O2 sensing. J. Biol. Chem. 275, 25130–25138 (2000).
  Article CAS PubMed Google Scholar
• Brunelle, J. K. et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell. Metab. 1, 409–414 (2005).
  Article CAS PubMed Google Scholar
• Selak, M. A. et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77–85 (2005).
  Article CAS PubMed Google Scholar
• Rustin, P. & Roetig, A. Inborn errors of complex II - Unusual human mitochondrial diseases. Biochim. Biophys. Acta 1553, 117–122 (2002).
  Article CAS PubMed Google Scholar
• Burnichon, N. et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011–3020 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ackrell, B. A. C. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466, 1–5 (2000).
  Article CAS PubMed Google Scholar
• Baysal, B. E. et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848–851 (2000).
  Article CAS PubMed Google Scholar
• Gimenez-Roqueplo, A. P. et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 69, 1186–1197 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Dekker, P. B. D. et al. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Pathol. 201, 480–486 (2003).
  Article CAS Google Scholar
• Astrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E. & Baysal, B. E. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum. Genet. 113, 228–237 (2003).
  Article PubMed Google Scholar
• Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S. & Schumacker, P. T. Loss of SdhB, but not SdhA, subunit of Complex. II triggers ROS-dependent HIF activation and tumorigenesis. Mol. Cell. Biol. 28, 718–731 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Owens, K. M. et al. Genomic instability induced by mutant succinate dehydrogenase subunit D (SDHD) is mediated by O2-• and H2O2 . Free Radic. Biol. Med. 52, 160–166 (2012).
  Article CAS PubMed Google Scholar
• Tomlinson, I. P. et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nature Genet. 30, 406–410 (2002).
  Article CAS PubMed Google Scholar
• Pollard, P. J. et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231–2239 (2005).
  Article CAS PubMed Google Scholar
• Isaacs, J. S. et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143–153 (2005).
  Article CAS PubMed Google Scholar
• Sudarshan, S. et al. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1α stabilization by glucose-dependent generation of reactive oxygen species. Mol. Cell. Biol. 29, 4080–4090 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385–388 (2012).
  Article CAS Google Scholar
• Semenza, G. L. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Invest. 123, 3664–3671 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, Y. et al. K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res. 22, 399–412 (2012).
  Article CAS PubMed Google Scholar
• Dang, C. V. et al. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253, 63–77 (1999).
  Article CAS PubMed Google Scholar
• Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782–18787 (2008).
  Article PubMed PubMed Central Google Scholar
• Li, F. et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25, 6225–6234 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Shim, H. et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl Acad. Sci. USA 94, 6658–6663 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Chandel, N. S., Trzyna, W. C., McClintock, D. S. & Schumacker, P. T. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J. Immunol. 165, 1013–1021 (2000).
  Article CAS PubMed Google Scholar
• Schumacker, P. T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10, 175–176 (2006).
  Article CAS PubMed Google Scholar
• Hashemy, S. I., Ungerstedt, J. S., Avval, F. Z. & Holmgren, A. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J. Biol. Chem. 281, 10691–10697 (2006).
  Article CAS PubMed Google Scholar
• Goodman, M., Bostick, R. M., Kucuk, O. & Jones, D. P. Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic. Biol. Med. 51, 1068–1084 (2011).
  Article CAS PubMed Google Scholar
• Creagan, E. T. et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N. Engl. J. Med. 301, 687–690 (1979).
  Article CAS PubMed Google Scholar
• Jung, H. J. et al. Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J. Biol. Chem. 285, 11584–11595 (2010).
  Article CAS PubMed PubMed Central Google Scholar